Liao 2004.

Methods	computer random table; use of identical appearing packages and capsules/ tablets from pharmacy; identical placebo tablets
Participants	480 women,average age 26 years; </= 49 days gestation confirmed by ultrsound; Exclusion criteria: abnormal menses, IUD in situ, contraindications for use of study medication; study conducted between November 2001 to June 2002 in 3 hospitals affiliated to University of Beijing,  China
Interventions	group 1: mifepristone: 50mg, then 12 hrs later 25mg, then 12 hrs later 50mg, and finally, 12 hrs later, 25mg (total: 150mg). 24 hrs after last dose 600mcg misoprostol orally group 2: mifepristone 30mg, then 15mg every 12 hours for 3 doses (total: 75mg). 24 hrs after last dose, 600mcg misoprostol orally.
Outcomes	complete abortion
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ adequate